<i>Carica papaya</i> Leaf Extract Silver Synthesized Nanoparticles Inhibit Dengue Type 2 Viral Replication In Vitro
The current global occurrence of dengue infection annually is approximately 400 million, with a case fatality rate of 2.5%. However, there are no antiviral agents. <i>Carica papaya</i> leaf extract is known for its medicinal value, due to the presence of organic compounds that possess an...
Main Authors: | Antonia Windkouni Bere, Omuyundo Mulati, James Kimotho, Florence Ng’ong’a |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/8/718 |
Similar Items
-
<i>Carica papaya</i> Leaf Juice for Dengue: A Scoping Review
by: Bee Ping Teh, et al.
Published: (2022-04-01) -
In-vitro antiviral activity of Carica papaya formulations against dengue virus type 2 and chikungunya virus
by: P. Patil, et al.
Published: (2022-12-01) -
Carica papaya extract in dengue: a systematic review and meta-analysis
by: Senaka Rajapakse, et al.
Published: (2019-10-01) -
Immunomodulatory Activities of <i>Carica papaya</i> L. Leaf Juice in a Non-Lethal, Symptomatic Dengue Mouse Model
by: Mohd Ridzuan Mohd Abd Razak, et al.
Published: (2021-04-01) -
Effect of doxycycline and doxycycline with carica papaya on thrombocytopenia and leucopenia in acute dengue fever patients
by: Vivek Pambhar, et al.
Published: (2022-01-01)